<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38339075</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>T-Cell Receptor Sequences Identify Combined Coxsackievirus-<i>Streptococci</i> Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus-<i>Clostridia</i> Infections for Type 1 Diabetes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1797</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25031797</ELocationID><Abstract><AbstractText>Recent research suggests that T-cell receptor (TCR) sequences expanded during human immunodeficiency virus and SARS-CoV-2 infections unexpectedly mimic these viruses. The hypothesis tested here is that TCR sequences expanded in patients with type 1 diabetes mellitus (T1DM) and autoimmune myocarditis (AM) mimic the infectious triggers of these diseases. Indeed, TCR sequences mimicking coxsackieviruses, which are implicated as triggers of both diseases, are statistically significantly increased in both T1DM and AM patients. However, TCRs mimicking <i>Clostridia</i> antigens are significantly expanded in T1DM, whereas TCRs mimicking <i>Streptococcal</i> antigens are expanded in AM. Notably, <i>Clostridia</i> antigens mimic T1DM autoantigens, such as insulin and glutamic acid decarboxylase, whereas <i>Streptococcal</i> antigens mimic cardiac autoantigens, such as myosin and laminins. Thus, T1DM may be triggered by combined infections of coxsackieviruses with <i>Clostridia</i> bacteria, while AM may be triggered by coxsackieviruses with <i>Streptococci.</i> These TCR results are consistent with both epidemiological and clinical data and recent experimental studies of cross-reactivities of coxsackievirus, <i>Clostridial</i>, and <i>Streptococcal</i> antibodies with T1DM and AM antigens. These data provide the basis for developing novel animal models of AM and T1DM and may provide a generalizable method for revealing the etiologies of other autoimmune diseases. Theories to explain these results are explored.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Root-Bernstein</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3298-9306</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013291" MajorTopicYN="N">Streptococcus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013290" MajorTopicYN="Y">Streptococcal Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011948" MajorTopicYN="N">Receptors, Antigen, T-Cell</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clostridia</Keyword><Keyword MajorTopicYN="N">Streptococci</Keyword><Keyword MajorTopicYN="N">T-cell receptors</Keyword><Keyword MajorTopicYN="N">anti-idiotype</Keyword><Keyword MajorTopicYN="N">antigen complementarity</Keyword><Keyword MajorTopicYN="N">autoimmune myocarditis</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">insulin</Keyword><Keyword MajorTopicYN="N">laminin</Keyword><Keyword MajorTopicYN="N">mimicry</Keyword><Keyword MajorTopicYN="N">myosin</Keyword><Keyword MajorTopicYN="N">synergism</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>11</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>10</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38339075</ArticleId><ArticleId IdType="pmc">PMC10855694</ArticleId><ArticleId IdType="doi">10.3390/ijms25031797</ArticleId><ArticleId IdType="pii">ijms25031797</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Root-Bernstein R. Autoreactive T-cell receptor (Vbeta/D/Jbeta) sequences in diabetes are homologous to insulin, glucagon, the insulin receptor, and the glucagon receptor. J. Mol. Recognit. 2009;22:177–187. doi: 10.1002/jmr.930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmr.930</ArticleId><ArticleId IdType="pubmed">19051206</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R.S. Autoimmunity and the microbiome: T-cell receptor mimicry of “self” and microbial antigens mediates self tolerance in holobionts. BioEssays. 2016;38:1068–1083. doi: 10.1002/bies.201600083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201600083</ArticleId><ArticleId IdType="pmc">PMC7161894</ArticleId><ArticleId IdType="pubmed">27594308</ArticleId></ArticleIdList></Reference><Reference><Citation>Moise L., Beseme S., Tassone R., Liu R., Kibria F., Terry F., Martin W., De Groot A.S. T cell epitope redundancy: Cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity. Expert Rev. Vaccines. 2016;15:607–617. doi: 10.1586/14760584.2016.1123098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1123098</ArticleId><ArticleId IdType="pubmed">26588466</ArticleId></ArticleIdList></Reference><Reference><Citation>Moise L., Terry F., Gutierrez A.H., Tassone R., Losikoff P., Gregory S.H., Bailey-Kellogg C., Martin W.D., De Groot A.S. Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection. Front. Microbiol. 2016;5:502. doi: 10.3389/fmicb.2014.00502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2014.00502</ArticleId><ArticleId IdType="pmc">PMC4186478</ArticleId><ArticleId IdType="pubmed">25339942</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauber A.I. A hypothesis: Establishing the microbiome through immune mimicry. Bioessays. 2016;38:1062. doi: 10.1002/bies.201600173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201600173</ArticleId><ArticleId IdType="pubmed">27581659</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiatczak B., Tauber A.I. Holoimmunity Revisited. Bioessays. 2018;40:e1800117. doi: 10.1002/bies.201800117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201800117</ArticleId><ArticleId IdType="pubmed">30264468</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. Human Immunodeficiency Virus Proteins Mimic Human T Cell Receptors Inducing Cross-Reactive Antibodies. Int. J. Mol. Sci. 2017;18:2091. doi: 10.3390/ijms18102091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102091</ArticleId><ArticleId IdType="pmc">PMC5666773</ArticleId><ArticleId IdType="pubmed">28972547</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R., Churchill E., Oliverio S. T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens. Int. J. Mol. Sci. 2023;24:1335. doi: 10.3390/ijms24021335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021335</ArticleId><ArticleId IdType="pmc">PMC9861234</ArticleId><ArticleId IdType="pubmed">36674851</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio A.L., Iliceto S. Genetically determined myocarditis: Clinical presentation and immunological characteristics. Curr. Opin. Cardiol. 2008;23:219–226. doi: 10.1097/HCO.0b013e3282fbf572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0b013e3282fbf572</ArticleId><ArticleId IdType="pubmed">18382209</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.S., Ligons D.L., Rose N.R. Genetic complexity of autoimmune myocarditis. Autoimmun. Rev. 2008;7:168–173. doi: 10.1016/j.autrev.2007.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2007.11.010</ArticleId><ArticleId IdType="pmc">PMC2233796</ArticleId><ArticleId IdType="pubmed">18190873</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Belle T.L., Coppieters K.T., von Herrath M.G. Type 1 diabetes: Etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011;91:79–118. doi: 10.1152/physrev.00003.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00003.2010</ArticleId><ArticleId IdType="pubmed">21248163</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugliese A. The multiple origins of Type 1 diabetes. Diabet. Med. 2013;30:135–146. doi: 10.1111/dme.12081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.12081</ArticleId><ArticleId IdType="pubmed">23181718</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilherme L., Köhler K.F., Postol E., Kalil J. Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann. Pediatr. Cardiol. 2011;4:13–21. doi: 10.4103/0974-2069.79617.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-2069.79617</ArticleId><ArticleId IdType="pmc">PMC3104525</ArticleId><ArticleId IdType="pubmed">21677799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon J.W., Ihm S.H., Kim K.W. Viruses as a triggering factor of type 1 diabetes and genetic markers related to the susceptibility to the virus-associated diabetes. Diabetes Res. Clin. Pract. 1989;7((Suppl. S1)):S47–S58. doi: 10.1016/0168-8227(89)90088-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8227(89)90088-0</ArticleId><ArticleId IdType="pubmed">2680367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D., Sauter P. Pathogenesis of type 1 diabetes mellitus: Interplay between enterovirus and host. Nat. Rev. Endocrinol. 2010;6:279–289. doi: 10.1038/nrendo.2010.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2010.27</ArticleId><ArticleId IdType="pubmed">20351698</ArticleId></ArticleIdList></Reference><Reference><Citation>Richer M.J., Horwitz M.S. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes. Autoimmun. Rev. 2009;8:611–615. doi: 10.1016/j.autrev.2009.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.02.006</ArticleId><ArticleId IdType="pubmed">19393207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaidane H., Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 2008;34:537–548. doi: 10.1016/j.diabet.2008.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2008.05.008</ArticleId><ArticleId IdType="pubmed">18951821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair A., Wolter T.R., Meyers A.J., Zipris D. Innate immune pathways in virus-induced autoimmune diabetes. Ann. N. Y. Acad. Sci. 2008;1150:139–142. doi: 10.1196/annals.1447.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1447.004</ArticleId><ArticleId IdType="pubmed">19120282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M.P., Alidjinou E.K., Hober D. Persistent coxsackievirus B infection and patho-genesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2022;18:503–516. doi: 10.1038/s41574-022-00688-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen M., Knip M., Hyöty H., Kulmala P., Hiltunen M., Vähäsalo P., Hovi T., Akerblom H.K. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Child. Diabetes Finl. (DiMe) Study Group J. Med. Virol. 1998;56:74–78. doi: 10.1002/(SICI)1096-9071(199809)56:1&lt;74::AID-JMV12&gt;3.0.CO;2-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199809)56:1&lt;74::AID-JMV12&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">9700636</ArticleId></ArticleIdList></Reference><Reference><Citation>Sané F., Moumna I., Hober D. Group B coxsackieviruses and autoimmunity: Focus on Type 1 diabetes. Expert. Rev. Clin. Immunol. 2011;7:357–366. doi: 10.1586/eci.11.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eci.11.11</ArticleId><ArticleId IdType="pubmed">21595602</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg E., Krause I. Infection and type 1 diabetes mellitus—A two edged sword? Autoimmun. Rev. 2009;8:682–686. doi: 10.1016/j.autrev.2009.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.02.017</ArticleId><ArticleId IdType="pubmed">19393195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammi N., Karvonen M., Tuomilehto J. Do microbes have a causal role in type 1 diabetes? Med. Sci. Monit. 2005;11:RA63-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15735577</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun H.S., Yoon J.W. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 2003;19:8–31. doi: 10.1002/dmrr.337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.337</ArticleId><ArticleId IdType="pubmed">12592641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fromantin M., Laverdant C. Le diabète de l’hépatite virale: À propos de vingt nouvelles observations [Diabetes following viral hepatitis: 20 recent cases] Diabete. 1970;18:121–125. (In French)</Citation><ArticleIdList><ArticleId IdType="pubmed">5509960</ArticleId></ArticleIdList></Reference><Reference><Citation>Franczak T. Cukrzyca w nastepstwie wirusowego zapalenia watroby [Diabetes following virus hepatitis] Pol. Tyg. Lek. 1969;24:1705–1706. (In Polish)</Citation><ArticleIdList><ArticleId IdType="pubmed">5360949</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosu V., Ahmed N., Paccagnini D., Gerlach G., Fadda G., Hasnain S.E., Zanetti S., Sechi L.A. Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with Type-1 but not Type-2 diabetes mellitus. PLoS ONE. 2009;4:e4386. doi: 10.1371/journal.pone.0004386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004386</ArticleId><ArticleId IdType="pmc">PMC2636876</ArticleId><ArticleId IdType="pubmed">19204799</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi L.A., Rosu V., Pacifico A., Fadda G., Ahmed N., Zanetti S. Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis. Clin. Vaccine Immunol. 2008;15:320–326. doi: 10.1128/CVI.00381-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00381-07</ArticleId><ArticleId IdType="pmc">PMC2238046</ArticleId><ArticleId IdType="pubmed">18077612</ArticleId></ArticleIdList></Reference><Reference><Citation>Satorres S., Alcaraz L., Di Genaro S. Association between high levels IL-8 and Staphylococcus aureus-specific IgA antibodies in subjects with type 1 diabetes mellitus from Argentina. Diabetes Res. Clin. Pract. 2007;77:489–491. doi: 10.1016/j.diabres.2007.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2007.01.006</ArticleId><ArticleId IdType="pubmed">17306409</ArticleId></ArticleIdList></Reference><Reference><Citation>Neophytou P.I., Roep B.O., Arden S.D., Muir E.M., Duinkerken G., Kallan A., de Vries R.R., Hutton J.C. T-cell epitope analysis using subtracted expression libraries (TEASEL): Application to a 38-kDA autoantigen recognized by T cells from an insulin-dependent diabetic patient. Proc. Natl. Acad. Sci. USA. 1996;93:2014–2018. doi: 10.1073/pnas.93.5.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.5.2014</ArticleId><ArticleId IdType="pmc">PMC39901</ArticleId><ArticleId IdType="pubmed">8700877</ArticleId></ArticleIdList></Reference><Reference><Citation>Marietti M., Gasbarrini A., Saracco G., Pellicano R. Helicobacter pylori infection and diabetes mellitus: The 2013 state of art. Panminerva Med. 2013;55:277–281.</Citation><ArticleIdList><ArticleId IdType="pubmed">24088801</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdellatif A.M., Jensen Smith H., Harms R.Z., Sarvetnick N.E. Human Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study. Front. Immunol. 2019;10:2623. doi: 10.3389/fimmu.2019.02623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02623</ArticleId><ArticleId IdType="pmc">PMC6857727</ArticleId><ArticleId IdType="pubmed">31781116</ArticleId></ArticleIdList></Reference><Reference><Citation>Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Novelo L.L., Casella G., Drew J.C., Ilonen J., Knip M., Hyöty H., et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011;5:82–91. doi: 10.1038/ismej.2010.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2010.92</ArticleId><ArticleId IdType="pmc">PMC3105672</ArticleId><ArticleId IdType="pubmed">20613793</ArticleId></ArticleIdList></Reference><Reference><Citation>Goffau M., Luopajärvi K., Knip M., Ilonen J., Ruohtula T., Härkönen T., Orivuori L., Hakala S., Welling G.W., Harmsen H.J., et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013;62:1238–1244. doi: 10.2337/db12-0526.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db12-0526</ArticleId><ArticleId IdType="pmc">PMC3609581</ArticleId><ArticleId IdType="pubmed">23274889</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C.T., Davis-Richardson A.G., Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Casella G., Drew J.C., Ilonen J., Knip M., et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE. 2011;610:e25792. doi: 10.1371/journal.pone.0025792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025792</ArticleId><ArticleId IdType="pmc">PMC3197175</ArticleId><ArticleId IdType="pubmed">22043294</ArticleId></ArticleIdList></Reference><Reference><Citation>Murri M., Leiva L., Gomez-Zumaquero J.M., Tinahones F.J., Cardona F. Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Med. 2013;11:46. doi: 10.1186/1741-7015-11-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-46</ArticleId><ArticleId IdType="pmc">PMC3621820</ArticleId><ArticleId IdType="pubmed">23433344</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaarala O. Human intestinal microbiota and Type 1 Diabetes. Curr. Diab. Rep. 2013;13:601–607. doi: 10.1007/s11892-013-0409-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-013-0409-5</ArticleId><ArticleId IdType="pubmed">23934614</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Herrath M.G., Holz A., Homann D., Oldstone M.B. Role of viruses in type I diabetes. Semin. Immunol. 1998;10:87–100. doi: 10.1006/smim.1997.0108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/smim.1997.0108</ArticleId><ArticleId IdType="pubmed">9529659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipris D. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. Clin. Immunol. 2009;131:11–23. doi: 10.1016/j.clim.2008.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2008.12.011</ArticleId><ArticleId IdType="pubmed">19185542</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu P.G., John T.J. Alteration of immune response to coxsackie B3 virus by streptozotocin in dual-aetiology diabetes mellitus in mouse. Indian J. Exp. Biol. 1987;25:17–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">3038739</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon J.W., London W.T., Curfman B.L., Brown R.L., Notkins A.L. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes. 1986;35:712–716. doi: 10.2337/diab.35.6.712.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.35.6.712</ArticleId><ArticleId IdType="pubmed">3011574</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.W., Taylor G., Basid A. The effect of pertussis vaccine on the insulin-dependent diabetes induced by streptozotocin in ice. Pediatr. Res. 1984;18:221–226. doi: 10.1203/00006450-198402000-00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-198402000-00021</ArticleId><ArticleId IdType="pubmed">6366724</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomaguchi H., Yogi Y., Kawatsu K., Okamura HOzawa Y., Kasatani T. Prevention of diabetes in non-obese diabetic mice by a single immunization with Mycobacterium leprae. Nihon Hansen. Gakkai Zasshi. 2002;71:31–38. doi: 10.5025/hansen.71.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.5025/hansen.71.31</ArticleId><ArticleId IdType="pubmed">11979756</ArticleId></ArticleIdList></Reference><Reference><Citation>Silveira P.A., Baxter A.G. The NOD mouse as a model of SLE. Autoimmunity. 2001;34:53–64. doi: 10.3109/08916930108994126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916930108994126</ArticleId><ArticleId IdType="pubmed">11681493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kühtreiber W.M., Faustman D.L. BCG Therapy for Type 1 Diabetes: Restoration of Balanced Immunity and Metabolism. Trends Endocrinol. Metab. 2019;30:80–92. doi: 10.1016/j.tem.2018.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2018.11.006</ArticleId><ArticleId IdType="pubmed">30600132</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nat. Med. 1998;4:781–785. doi: 10.1038/nm0798-781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0798-781</ArticleId><ArticleId IdType="pubmed">9662368</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi C., von Herrath M. How viral infections affect the autoimmune process leading to type 1 diabetes. Cell. Immunol. 2005;233:125–132. doi: 10.1016/j.cellimm.2005.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2005.04.009</ArticleId><ArticleId IdType="pubmed">15963965</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose N.R., Hill S.L. The pathogenesis of postinfectious myocarditis. Clin. Immunol. Immunopathol. 1996;80:S92–S99. doi: 10.1006/clin.1996.0146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clin.1996.0146</ArticleId><ArticleId IdType="pubmed">8811068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciháková D., Rose N.R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008;99:95–114. doi: 10.1016/S0065-2776(08)00604-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2776(08)00604-4</ArticleId><ArticleId IdType="pubmed">19117533</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams D., Derrick G., Penny D.J., Shinebourne E.A., Redington A.N. Cardiac complications in children following infection with varicella zoster virus. Cardiol. Young. 2001;11:647–652. doi: 10.1017/S1047951101001019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951101001019</ArticleId><ArticleId IdType="pubmed">11813917</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles N.E., Ni J., Kearney D.L., Pauschinger M., Schultheiss H.P., McCarthy R., Hare J., Bricker J.T., Bowles K.R., Towbin J.A. Detection of viruses in myocardial tissues by polymerase chain reaction: Evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 2003;42:466–472. doi: 10.1016/S0735-1097(03)00648-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(03)00648-X</ArticleId><ArticleId IdType="pubmed">12906974</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato Y., Yamada T., Matsumori A. Hepatitis C virus and cardiomyopathy. In: Matsumori A., editor. Cardiomyopathies and Heart Failure: Biomolecular, Infectious, and Immune Mechanisms. Kluwer Academic Publishers; Boston, MA, USA: 2003. pp. 325–339.</Citation></Reference><Reference><Citation>Pauschinger M., Bowles N.E., Fuentes-Garcia F.J., Pham V., Kuhl U., Schwimmbeck P.L., Schultheiss H.P., Towbin J.A. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation. 1999;99:1348–1354. doi: 10.1161/01.CIR.99.10.1348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.10.1348</ArticleId><ArticleId IdType="pubmed">10077520</ArticleId></ArticleIdList></Reference><Reference><Citation>Panhoweit S., Lamparter S., Schoppet M., Maisch B. Parvovirus B19 genome in endomyocardial biopsy specimens. Circulation. 2004;109:e179.</Citation><ArticleIdList><ArticleId IdType="pubmed">15078808</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahfoud F., Gärtner B., Kindermann M., Ukena C., Gadomski K., Klingel K., Kandolf R., Böhm M., Kindermann I. Virus serology in patients with suspected myocarditis: Utility or futility? Eur. Heart J. 2011;32:897–903. doi: 10.1093/eurheartj/ehq493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq493</ArticleId><ArticleId IdType="pubmed">21217143</ArticleId></ArticleIdList></Reference><Reference><Citation>Andréoletti L., Lévêque N., Boulagnon C., Brasselet C., Fornes P. Viral causes of human myocarditis. Arch. Cardiovasc. Dis. 2009;102:559–568. doi: 10.1016/j.acvd.2009.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2009.04.010</ArticleId><ArticleId IdType="pubmed">19664576</ArticleId></ArticleIdList></Reference><Reference><Citation>Halsell J.S., Riddle J.R., Atwood J.E., Gardner P., Shope R., Poland G.A., Gray G.C., Ostroff S., Eckart R.E., Hospenthal D.R., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 2003;289:3283–3289. doi: 10.1001/jama.289.24.3283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.24.3283</ArticleId><ArticleId IdType="pubmed">12824210</ArticleId></ArticleIdList></Reference><Reference><Citation>Henao-Martínez A.F., Schwartz D.A., Yang I.V. Chagasic cardiomyopathy, from acute to chronic: Is this mediated by host susceptibility factors? Trans. R. Soc. Trop. Med. Hyg. 2012;106:521–527. doi: 10.1016/j.trstmh.2012.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trstmh.2012.06.006</ArticleId><ArticleId IdType="pubmed">22819769</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M.W. Streptococcus and rheumatic fever. Curr. Opin. Rheumatol. 2012;24:408–416. doi: 10.1097/BOR.0b013e32835461d3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e32835461d3</ArticleId><ArticleId IdType="pmc">PMC3645882</ArticleId><ArticleId IdType="pubmed">22617826</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilherme L., Kalil J. Rheumatic fever: From sore throat to autoimmune heart lesions. Int. Arch. Allergy Immunol. 2004;134:56–64. doi: 10.1159/000077915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000077915</ArticleId><ArticleId IdType="pubmed">15103230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikder S., Williams N.L., Sorenson A.E., Alim M.A., Vidgen M.E., Moreland N.J., Rush C.M., Simpson R.S., Govan B.L., Norton R.E., et al. Group G Streptococcus Induces an Autoimmune Carditis Mediated by Interleukin 17A and Interferon γ in the Lewis Rat Model of Rheumatic Heart Disease. J. Infect. Dis. 2018;218:324–335. doi: 10.1093/infdis/jix637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix637</ArticleId><ArticleId IdType="pubmed">29236994</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaryus A.N., Revere D.J., Steinberg B. Recurrent reversible dilated cardiomyopathy secondary to viral and streptococcal pneumonia vaccine-associated myocarditis. Cardiol. Rev. 2006;14:e1–e4. doi: 10.1097/01.crd.0000174803.68564.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.crd.0000174803.68564.65</ArticleId><ArticleId IdType="pubmed">16788323</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart G.C., Lopez-Molina J., Gottumukkala R.V., Rosner G.F., Anello M.S., Hecht J.L., Winters G.L., Padera R.F., Baughman K.L., Lipes M.A. Myocardial parvovirus B19 persistence: Lack of association with clinicopathologic phenotype in adults with heart failure. Circ. Heart Fail. 2011;4:71–78. doi: 10.1161/CIRCHEARTFAILURE.110.958249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.110.958249</ArticleId><ArticleId IdType="pmc">PMC3047418</ArticleId><ArticleId IdType="pubmed">21097605</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling P.J., Poloniecki L.A., Caforio A.L., Davies M.J., Booth J.C., McKenna W.J. A prospective case-control study of antibodies to Coxsackie B virus in idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 1994;23:593–598. doi: 10.1016/0735-1097(94)90742-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(94)90742-0</ArticleId><ArticleId IdType="pubmed">8113540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciháková D., Sharma R.B., Fairweather D., Afanasyeva M., Rose N.R. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 2004;102:175–193.</Citation><ArticleIdList><ArticleId IdType="pubmed">15286386</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Stafford K.A., Sung Y.K. Update on coxsackievirus B3 myocarditis. Curr. Opin. Rheumatol. 2012;24:401–407. doi: 10.1097/BOR.0b013e328353372d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328353372d</ArticleId><ArticleId IdType="pmc">PMC4536812</ArticleId><ArticleId IdType="pubmed">22488075</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers J.M., Fairweather D., Huber S.A., Cunningham M.W. Autoimmune myocarditis, valvulitis, and cardiomyopathy. Curr. Protoc. Immunol. 2013;101:15.14.1–15.14.51. doi: 10.1002/0471142735.im1514s101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142735.im1514s101</ArticleId><ArticleId IdType="pmc">PMC3672855</ArticleId><ArticleId IdType="pubmed">23564686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson C.M., O’Donoghue H.L., Reed W.D. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: A model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology. 1992;75:513–519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1384748</ArticleId><ArticleId IdType="pubmed">1315309</ArticleId></ArticleIdList></Reference><Reference><Citation>Masedunskas A., Porat-Shliom N., Weigert R. Linking differences in membrane tension with the requirement for a contractile actomyosin scaffold during exocytosis in salivary glands. Commun. Integr. Biol. 2012;5:84–87. doi: 10.4161/cib.18258.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cib.18258</ArticleId><ArticleId IdType="pmc">PMC3291323</ArticleId><ArticleId IdType="pubmed">22482019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorton D., Blyth S., Gorton J.G., Govan B., Ketheesan N. An alternative technique for the induction of autoimmune valvulitis in a rat model of rheumatic heart disease. J. Immunol. Methods. 2010;355:80–85. doi: 10.1016/j.jim.2010.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2010.02.013</ArticleId><ArticleId IdType="pubmed">20206182</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Zhou H., Huang J., Huang H., Feng Z., Mei K., Yu B., Su Z., Gu J. An animal model of chronic rheumatic valvulitis induced by formalin-killed streptococci. Rheumatol. Int. 2010;30:1621–1625. doi: 10.1007/s00296-009-1246-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-009-1246-3</ArticleId><ArticleId IdType="pubmed">20012632</ArticleId></ArticleIdList></Reference><Reference><Citation>Burch G.E., Giles T.D. The role of viruses in the production of heart disease. Am. J. Cardiol. 1972;29:231–240. doi: 10.1016/0002-9149(72)90634-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(72)90634-0</ArticleId><ArticleId IdType="pubmed">4336266</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R.S., Vonck J., Podufaly A. Antigenic complementarity between coxsackie virus and streptococci in rheumatic heart disease and myocarditis. Autoimmunity. 2009;22:177–187.</Citation><ArticleIdList><ArticleId IdType="pubmed">18608177</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale J.B., Fischetti V.A., Carapetis J.R., Steer A.C., Sow S., Kumar R., Mayosi B.M., Rubin F.A., Mulholland K., Hombach J.M., et al. Group A streptococcal vaccines: Paving a path for accelerated development. Vaccine. 2013;31((Suppl. S2)):B216–B222. doi: 10.1016/j.vaccine.2012.09.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.09.045</ArticleId><ArticleId IdType="pubmed">23598485</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaher S.R., Kassem A.S., Hughes J.J. Coxsackie virus infections in rheumatic fever. Indian J. Pediatr. 1993;60:289–298. doi: 10.1007/BF02822194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02822194</ArticleId><ArticleId IdType="pubmed">8244506</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh L., Chandrasekar S., Rao R.S., Ravi V., Badrinath S. Coxsackie virus and rheumatic fever. A correlative study. J. Assoc. Physicians India. 1989;37:582–585.</Citation><ArticleIdList><ArticleId IdType="pubmed">2561125</ArticleId></ArticleIdList></Reference><Reference><Citation>Olgunturk R., Okur I., Cirak M.Y., Oguz A.D., Akalin N., Turet S., Tunaoglu S. The role of viral agents in aetiopathogenesis of acute rheumatic fever. Clin Rheumatol. 2011;30:15–20. doi: 10.1007/s10067-010-1447-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-010-1447-x</ArticleId><ArticleId IdType="pubmed">20401762</ArticleId></ArticleIdList></Reference><Reference><Citation>Vikerfors T., Stjerna A., Olcén P., Malmcrona R., Magnius L. Acute myocarditis. Serologic diagnosis, clinical findings and follow-up. Acta Med. Scand. 1988;223:45–52. doi: 10.1111/j.0954-6820.1988.tb15763.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0954-6820.1988.tb15763.x</ArticleId><ArticleId IdType="pubmed">2831699</ArticleId></ArticleIdList></Reference><Reference><Citation>Górska A., Urban M., Głowińska B., Kowalewski M. Czy zakazenie paciorkowcem grupy A jest wyłaczna infekcyjna przyczyna goraczki reumatycznej?—Opis przebiegu goraczki reumatycznej u 11-letniego chłopca ze współistniejaca infekcja wirusem Coxackie B1 [Is infection with group A streptococcus the only reason for rheumatic fever?—A case report of rheumatic fever coexisting with Coxsackie B1 virus infection] Przegl. Lek. 1998;55:418–419. (In Polish)</Citation><ArticleIdList><ArticleId IdType="pubmed">10021888</ArticleId></ArticleIdList></Reference><Reference><Citation>Novikov I. O diagnostike nerevmaticheskikh miokarditov [Diagnosis of nonrheumatic myocarditis] Kardiologiia. 1983;23:50–55. (In Russian)</Citation><ArticleIdList><ArticleId IdType="pubmed">6876548</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotor F., Zavate O., Finichiu M., Avram G., Ivan A. Enterovirus contamination of swimming pool water; correlation with bacteriological indicators. Virologie. 1983;34:251–256.</Citation><ArticleIdList><ArticleId IdType="pubmed">6318427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kogut E.P., Levashova N.V., Bondarenko A.P., Zherdeva A.I., Shuvalova I.A. Eksperimental’noe izuchenie koksaki-streptokokkovoĭ infektsii [Experimental study of Coxsackie-streptococcal infection] Vopr. Virusol. 1978:690–695. (In Russian)</Citation><ArticleIdList><ArticleId IdType="pubmed">219625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., Poller W., Kandolf R., Schultheisss H.P. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. 2005;111:887–893. doi: 10.1161/01.CIR.0000155616.07901.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000155616.07901.35</ArticleId><ArticleId IdType="pubmed">15699250</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenberghe N., Leveque N., Corcia P., Brunaud-Danel V., Salort-Campana E., Besson G., Tranchant C., Clavelou P., Beaulieux F., Ecochard R., et al. Cerebrospinal fluid detection of enterovirus genome in ALS: A study of 242 patients and 354 controls. Amyotroph. Lateral Scler. 2010;11:277–282. doi: 10.3109/17482960903262083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903262083</ArticleId><ArticleId IdType="pubmed">19900148</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafyllopoulou A., Tapinos N., Moutsopoulos H.M. Evidence for coxsackievirus infection in primary Sjögren’s syndrome. Arthritis Rheum. 2004;50:2897–2902. doi: 10.1002/art.20463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20463</ArticleId><ArticleId IdType="pubmed">15457458</ArticleId></ArticleIdList></Reference><Reference><Citation>Stathopoulou E.A., Routsias J.G., Stea E.A., Moutsopoulos H.M., Tzioufas A.G. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of coxsackie virus 2B protein. Clin. Exp. Immunol. 2005;141:148–154. doi: 10.1111/j.1365-2249.2005.02812.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2005.02812.x</ArticleId><ArticleId IdType="pmc">PMC1809402</ArticleId><ArticleId IdType="pubmed">15958081</ArticleId></ArticleIdList></Reference><Reference><Citation>Utomo S.W., Putri J.F. Infections as Risk Factor of Sjögren’s Syndrome. Open Access Rheumatol. 2020;12:257–266. doi: 10.2147/OARRR.S276727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OARRR.S276727</ArticleId><ArticleId IdType="pmc">PMC7667172</ArticleId><ArticleId IdType="pubmed">33204185</ArticleId></ArticleIdList></Reference><Reference><Citation>Olival G.S., Lima B.M., Sumita L.M., Serafim V., Fink M.C., Nali L.H., Romano C.M., Thomaz R.B., Cavenaghi V.B., Tilbery C.P., et al. Multiple sclerosis and herpesvirus interaction. Arq. Neuropsiquiatr. 2013;71:727–730. doi: 10.1590/0004-282X20130160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20130160</ArticleId><ArticleId IdType="pubmed">24141514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Zhou J., Wei X., Wang X., Li Y., Peng B., Niu T. The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia. Hematology. 2013;18:295–299. doi: 10.1179/1607845413Y.0000000084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1607845413Y.0000000084</ArticleId><ArticleId IdType="pubmed">23540727</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R., Couturier J. Antigenic complementarity in the origins of autoimmunity: A general theory illustrated with a case study of idiopathic thrombocytopenia purpura. Clin. Dev. Immunol. 2006;13:49–65. doi: 10.1080/17402520600578731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17402520600578731</ArticleId><ArticleId IdType="pmc">PMC2270743</ArticleId><ArticleId IdType="pubmed">16603444</ArticleId></ArticleIdList></Reference><Reference><Citation>Draborg A.H., Duus K., Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin. Dev. Immunol. 2013;2013:535–538. doi: 10.1155/2013/535738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/535738</ArticleId><ArticleId IdType="pmc">PMC3766599</ArticleId><ArticleId IdType="pubmed">24062777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivity S., Arango M.T., Ehrenfeld M., Tehori O., Shoenfeld Y., Anaya J.M., Agmon-Levin N. Infection and autoimmunity in Sjogren’s syndrome: A clinical study and comprehensive review. J. Autoimmun. 2014;51:17–22. doi: 10.1016/j.jaut.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2014.02.008</ArticleId><ArticleId IdType="pubmed">24637076</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenblyum E.V., Allen U.D., Silverman E.D., Levy D.M. Cytomegalovirus infection in childhood-onset systemic lupus erythematosus. Int. J. Clin. Rheumtol. 2013;8:137–146. doi: 10.2217/ijr.12.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ijr.12.82</ArticleId><ArticleId IdType="pmc">PMC3920748</ArticleId><ArticleId IdType="pubmed">24527062</ArticleId></ArticleIdList></Reference><Reference><Citation>Caudie C., Quittard Pinon A., Taravel D., Sivadon-Tardy V., Orlikowski D., Rozenberg F., Sharshar T., Raphaël J.C., Gaillard J.L. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients. J. Neurol. 2011;258:1958–1964. doi: 10.1007/s00415-011-6042-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6042-9</ArticleId><ArticleId IdType="pubmed">21516465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Schiavo A., Ruocco E., Brancaccio G., Caccavale S., Ruocco V., Wolf R. Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies. Clin. Dermatol. 2013;31:391–399. doi: 10.1016/j.clindermatol.2013.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clindermatol.2013.01.006</ArticleId><ArticleId IdType="pubmed">23806156</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. Rethinking Molecular Mimicry in Rheumatic Heart Disease and Autoimmune Myocarditis: Laminin, Collagen IV, CAR, and B1AR as Initial Targets of Disease. Front. Pediatr. 2014;2:85. doi: 10.3389/fped.2014.00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2014.00085</ArticleId><ArticleId IdType="pmc">PMC4137453</ArticleId><ArticleId IdType="pubmed">25191648</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R., Fairweather D. Unresolved issues in theories of autoimmune disease using myocarditis as a framework. J. Theor. Biol. 2015;375:101–123. doi: 10.1016/j.jtbi.2014.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2014.11.022</ArticleId><ArticleId IdType="pmc">PMC4417457</ArticleId><ArticleId IdType="pubmed">25484004</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R., Fairweather D. Complexities in the relationship between infection and autoimmunity. Curr. Allergy Asthma Rep. 2014;14:407. doi: 10.1007/s11882-013-0407-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-013-0407-3</ArticleId><ArticleId IdType="pmc">PMC3926441</ArticleId><ArticleId IdType="pubmed">24352912</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R., Chiles K., Huber J., Ziehl A., Turke M., Pietrowicz M. Clostridia and Enteroviruses as Synergistic Triggers of Type 1 Diabetes Mellitus. Int. J. Mol. Sci. 2023;24:8336. doi: 10.3390/ijms24098336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098336</ArticleId><ArticleId IdType="pmc">PMC10179352</ArticleId><ArticleId IdType="pubmed">37176044</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Batchuluun B., Ho L., Zhu D., Prentice K.J., Bhattacharjee A., Zhang M., Pourasgari F., Hardy A.B., Taylor K.M., et al. Characterization of Zinc Influx Transporters (ZIPs) in Pancreatic β Cells: Roles in Regulating Cytosolic Zinc Homeostasis and Insulin Secretion. J. Biol. Chem. 2015;290:18757–18769. doi: 10.1074/jbc.M115.640524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.640524</ArticleId><ArticleId IdType="pmc">PMC4513131</ArticleId><ArticleId IdType="pubmed">25969539</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson G.L., Cordle S.R., Henderson E., Weil P.A., Teitelman G., Stein R. Isolation and characterization of a novel transcription factor that binds to and activates insulin control element-mediated expression. Mol. Cell Biol. 1994;14:6704–6714. doi: 10.1128/mcb.14.10.6704-6714.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.14.10.6704-6714.1994</ArticleId><ArticleId IdType="pmc">PMC359201</ArticleId><ArticleId IdType="pubmed">7935390</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson G.L., Henderson E., Massari M.E., Murre C., Stein R. c-jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products. Mol. Cell Biol. 1995;15:1398–1404. doi: 10.1128/MCB.15.3.1398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.15.3.1398</ArticleId><ArticleId IdType="pmc">PMC230364</ArticleId><ArticleId IdType="pubmed">7862133</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkin T.J., Nicholson S. Autoantibodies against human insulin. Br. Med. J. 1984;288:349–352. doi: 10.1136/bmj.288.6414.349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.288.6414.349</ArticleId><ArticleId IdType="pmc">PMC1444218</ArticleId><ArticleId IdType="pubmed">6419924</ArticleId></ArticleIdList></Reference><Reference><Citation>Verge C.F., Stenger D., Bonifacio E., Colman P.G., Pilcher C., Bingley P.J., Eisenbarth G.S. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes. 1998;47:1857–1866. doi: 10.2337/diabetes.47.12.1857.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.47.12.1857</ArticleId><ArticleId IdType="pubmed">9836516</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M.W. Rheumatic fever, autoimmunity, and molecular mimicry: The streptococcal connection. Int. Rev. Immunol. 2014;33:314–329. doi: 10.3109/08830185.2014.917411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2014.917411</ArticleId><ArticleId IdType="pmc">PMC4669348</ArticleId><ArticleId IdType="pubmed">24892819</ArticleId></ArticleIdList></Reference><Reference><Citation>Vreugdenhil G.R., Geluk A., Ottenhoff T.H., Melchers W.J., Roep B.O., Galama J.M. Molecular mimicry in diabetes mellitus: The homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia. 1998;41:40–46. doi: 10.1007/s001250050864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250050864</ArticleId><ArticleId IdType="pubmed">9498628</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela-Calvino R., Skowera A., Arif S., Peakman M. Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein. J. Virol. 2004;78:13399–13408. doi: 10.1128/JVI.78.24.13399-13408.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.24.13399-13408.2004</ArticleId><ArticleId IdType="pmc">PMC533958</ArticleId><ArticleId IdType="pubmed">15564450</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulli T., Lankinen H., Roivainen M., Hyypiä T. Antigenic sites of coxsackievirus A9. Virology. 1998;240:202–212. doi: 10.1006/viro.1997.8908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1997.8908</ArticleId><ArticleId IdType="pubmed">9454693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis R.J., Varela-Calvino R., Tree T.I., Peakman M. HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides. Immunology. 2005;116:337–346. doi: 10.1111/j.1365-2567.2005.02233.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2005.02233.x</ArticleId><ArticleId IdType="pmc">PMC1802420</ArticleId><ArticleId IdType="pubmed">16236123</ArticleId></ArticleIdList></Reference><Reference><Citation>Marttila J., Juhela S., Vaarala O., Hyöty H., Roivainen M., Hinkkanen A., Vilja P., Simell O., Ilonen J. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology. 2001;284:131–141. doi: 10.1006/viro.2001.0917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.0917</ArticleId><ArticleId IdType="pubmed">11352674</ArticleId></ArticleIdList></Reference><Reference><Citation>Marttila J., Hyöty H., Vilja P., Härkönen T., Alho A., Roivainen M., Hyypiä T., Ilonen J. T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses. Virology. 2002;293:217–224. doi: 10.1006/viro.2001.1259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1259</ArticleId><ArticleId IdType="pubmed">11886241</ArticleId></ArticleIdList></Reference><Reference><Citation>Marttila J., Hyöty H., Näntö-Salonen K., Simell O., Ilonen J. Epitopes recognized by CBV4 responding T cells: Effect of type 1 diabetes and associated HLA-DR-DQ haplotypes. Virology. 2004;319:27–35. doi: 10.1016/j.virol.2003.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2003.10.011</ArticleId><ArticleId IdType="pubmed">14967485</ArticleId></ArticleIdList></Reference><Reference><Citation>Cello J., Strannegard O., Svennerholm B. A study of the cellular immune response to enteroviruses in humans: Identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses. J. Gen. Virol. 1996;77:2097–2108. doi: 10.1099/0022-1317-77-9-2097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-77-9-2097</ArticleId><ArticleId IdType="pubmed">8811009</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonen-Tikka M.L., Hiekka A.K., Klemola P., Poussa T., Ludvigsson J., Korpela R., Vaarala O., Roivainen M. Early human enterovirus infections in healthy Swedish children participating in the PRODIA pilot study. J. Med. Virol. 2012;84:923–930. doi: 10.1002/jmv.23284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23284</ArticleId><ArticleId IdType="pubmed">22499016</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers S.A., Nield A., Chew G.S., Myers M.A. The zinc transporter, Slc39a7 (Zip7) is implicated in glycaemic control in skeletal muscle cells. PLoS ONE. 2013;8:e79316. doi: 10.1371/journal.pone.0079316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079316</ArticleId><ArticleId IdType="pmc">PMC3827150</ArticleId><ArticleId IdType="pubmed">24265765</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S.A., Moraska A., Cunningham M. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci. Proc. Natl. Acad. Sci. USA. 1994;91:5543–5547. doi: 10.1073/pnas.91.12.5543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.12.5543</ArticleId><ArticleId IdType="pmc">PMC44032</ArticleId><ArticleId IdType="pubmed">8202524</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S.A., Cunningham M.W. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. J. Immunol. 1996;156:3528–3534. doi: 10.4049/jimmunol.156.9.3528.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.156.9.3528</ArticleId><ArticleId IdType="pubmed">8617982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lönnrot M., Hyöty H., Knip M., Roivainen M., Kulmala P., Leinikki P., Akerblom H.K. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Childhood Dia-betes in Finland Study Group. Clin. Exp. Immunol. 1996;104:398–405. doi: 10.1046/j.1365-2249.1996.60771.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.1996.60771.x</ArticleId><ArticleId IdType="pmc">PMC2200444</ArticleId><ArticleId IdType="pubmed">9099922</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-Fernández F., Gallo A., Nuti F., Altamore L., Del Vescovo G.G., Traldi P., Ragazzi E., Rovero P., Lapolla A., Papini A.M. Cross-reactive peptide epitopes of Enterovirus Coxsackie B4 and human glutamic acid decarboxylase detecting anti-bodies in latent autoimmune diabetes in adults versus type 1 diabetes. Clin. Chim. Acta. 2021;515:73–79. doi: 10.1016/j.cca.2021.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2021.01.002</ArticleId><ArticleId IdType="pubmed">33422493</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottumukkala R.V., Lv H., Cornivelli L., Wagers A.J., Kwong R.Y., Bronson R., Stewart G.C., Schulze P.C., Chutkow W., Wolpert H.A., et al. Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes. Sci. Transl. Med. 2012;4:138ra80. doi: 10.1126/scitranslmed.3003551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3003551</ArticleId><ArticleId IdType="pmc">PMC4303259</ArticleId><ArticleId IdType="pubmed">22700956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipes M.A., Galderisi A. Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes. Curr. Diab. Rep. 2015;15:30. doi: 10.1007/s11892-015-0598-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-015-0598-1</ArticleId><ArticleId IdType="pmc">PMC4376963</ArticleId><ArticleId IdType="pubmed">25821130</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckel R.H., Eisenbarth G.S. Autoimmune diabetes inflames the heart. Sci. Transl. Med. 2012;4:138fs18. doi: 10.1126/scitranslmed.3004219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004219</ArticleId><ArticleId IdType="pubmed">22700952</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddings A.C., Shenoi A.N., Morales Pozzo A., Kiessling S.G. Hemolytic uremic syndrome complicated by Clostridium septicum bacteremia and new-onset type 1 diabetes mellitus. Report of a case. Clin. Nephrol. 2017;87:207–211. doi: 10.5414/CN109049.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CN109049</ArticleId><ArticleId IdType="pubmed">28211788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzai S., Rifai A.O., Webb S., Rifai K., Reiner A. Probable Clostridium septicum pneumocephalus in a user of natural remedies with newly diagnosed diabetes mellitus type 1. IDCases. 2019;17:e00581. doi: 10.1016/j.idcr.2019.e00581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2019.e00581</ArticleId><ArticleId IdType="pmc">PMC6610224</ArticleId><ArticleId IdType="pubmed">31312601</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C., Xu Y., Ji J., Wei J., Jiang Y., Yang Y., Yang M., Huang H., Zou R., Fang C., et al. Intestinal microbiota has important effect on severity of hand foot and mouth disease in children. BMC Infect. Dis. 2021;21:1062. doi: 10.1186/s12879-021-06748-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06748-7</ArticleId><ArticleId IdType="pmc">PMC8513321</ArticleId><ArticleId IdType="pubmed">34645414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Mou D., Li T., Chen Z., Ma C., Liang L., He Q. Integrated analysis reveals important differences in the gut and oropharyngeal microbiota between children with mild and severe hand, foot, and mouth disease. Emerg. Microbes Infect. 2023;12:2192819. doi: 10.1080/22221751.2023.2192819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2192819</ArticleId><ArticleId IdType="pmc">PMC10071984</ArticleId><ArticleId IdType="pubmed">36927539</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Lan Z., Wen Y., Zheng C., Rong Z., Liu T., Chen S., Yang X., Zheng H., Wu W. Synbiotics Supplements Lower the Risk of Hand, Foot, and Mouth Disease in Children, Potentially by Providing Resistance to Gut Microbiota Dysbiosis. Front. Cell Infect. Microbiol. 2021;11:729756. doi: 10.3389/fcimb.2021.729756.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.729756</ArticleId><ArticleId IdType="pmc">PMC8515124</ArticleId><ArticleId IdType="pubmed">34660342</ArticleId></ArticleIdList></Reference><Reference><Citation>Muniain-Mujika I., Calvo M., Lucena F., Girones R. Comparative analysis of viral pathogens and potential indicators in shellfish. Int. J. Food Microbiol. 2003;83:75–85. doi: 10.1016/S0168-1605(02)00324-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1605(02)00324-0</ArticleId><ArticleId IdType="pubmed">12672594</ArticleId></ArticleIdList></Reference><Reference><Citation>LaBelle R.L., Gerba C.P., Goyal S.M., Melnick J.L., Cech I., Bogdan G.F. Relationships between environmental factors, bacterial indicators, and the occurrence of enteric viruses in estuarine sediments. Appl. Environ. Microbiol. 1980;39:588–596. doi: 10.1128/aem.39.3.588-596.1980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aem.39.3.588-596.1980</ArticleId><ArticleId IdType="pmc">PMC291383</ArticleId><ArticleId IdType="pubmed">6247974</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R.S., Podufaly A. Autoreactive T-cell receptor (Vbeta/D/Jbeta) sequences in diabetes recognize insulin, the insulin receptor, and each other, and are targets of insulin antibodies. Open Autoimmun. J. 2012;4:10–22. doi: 10.2174/1876894601204010010.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1876894601204010010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudy G., Stone N., Harrison L.C., Colman P.G., McNair P., Brusic V., French M.B., Honeyman M.C., Tait B., Lew A.M. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1995;1:625–633. doi: 10.1007/BF03401603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03401603</ArticleId><ArticleId IdType="pmc">PMC2229979</ArticleId><ArticleId IdType="pubmed">8529129</ArticleId></ArticleIdList></Reference><Reference><Citation>Geluk A., van Meijgaarden K.E., Schloot N.C., Drijfhout J.W., Ottenhoff T.H., Roep B.O. HLA-DR binding analysis of peptides from islet antigens in IDDM. Diabetes. 1998;47:1594–1601. doi: 10.2337/diabetes.47.10.1594.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.47.10.1594</ArticleId><ArticleId IdType="pubmed">9753297</ArticleId></ArticleIdList></Reference><Reference><Citation>Schloot N.C., Roep B.O., Wegmann D.R., Yu L., Wang T.B., Eisenbarth G.S. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia. 1997;40:332–338. doi: 10.1007/s001250050683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250050683</ArticleId><ArticleId IdType="pubmed">9084973</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay L., Yin-Murphy M., Chua P.H., Koh L.H. Prevalence of coxsackievirus B antibody in patients with suspected rheumatic fever and rheumatic heart disease. Singap. Med. J. 1983;24:37–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">6306845</ArticleId></ArticleIdList></Reference><Reference><Citation>Pongpanich B., Boonpucknavig S., Wasi C., Tanphaichitr P., Boonpucknavig V. Immunopathology of acute rheumatic fever and rheumatic heart disease. The demonstration of Coxsackie group B viral antigen in the myocardium. Clin. Rheumatol. 1983;2:217–222. doi: 10.1007/BF02041393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02041393</ArticleId><ArticleId IdType="pubmed">6088158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaznacheev V.P., Iavorovskaia V.E. Bacterial-viral coalition in the etiology of rheumatic heart disease. Ter. Arkh. 1973;45:15–23. (In Russian)</Citation><ArticleIdList><ArticleId IdType="pubmed">4770016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M.W. T cell mimicry in inflammatory heart disease. Mol. Immunol. 2004;40:1121–1127. doi: 10.1016/j.molimm.2003.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2003.11.023</ArticleId><ArticleId IdType="pubmed">15036918</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami R.S., Oldstone M.B., Wroblewska Z., Frankel M.E., Koprowski H. Molecular mimicry in virus infection: Crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc. Natl. Acad. Sci. USA. 1983;80:2346–2350. doi: 10.1073/pnas.80.8.2346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.80.8.2346</ArticleId><ArticleId IdType="pmc">PMC393817</ArticleId><ArticleId IdType="pubmed">6300911</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami R.S., Oldstone M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science. 1985;230:1043–1045. doi: 10.1126/science.2414848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2414848</ArticleId><ArticleId IdType="pubmed">2414848</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J.M. Molecular mimicry: Can. epitope mimicry induce autoimmune disease? Immunol. Cell Biol. 1997;75:113–126. doi: 10.1038/icb.1997.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.1997.16</ArticleId><ArticleId IdType="pmc">PMC7165643</ArticleId><ArticleId IdType="pubmed">9107563</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose N.R., Mackay I.R. Molecular mimicry: A critical look at exemplary instances in human diseases. Cell Mol. Life Sci. 2000;57:542–551. doi: 10.1007/PL00000716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00000716</ArticleId><ArticleId IdType="pmc">PMC11146766</ArticleId><ArticleId IdType="pubmed">11130454</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoist C., Mathis D. Autoimmunity provoked by infection: How good is the case for T cell epitope mimicry? Nat. Immunol. 2001;2:797–801. doi: 10.1038/ni0901-797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni0901-797</ArticleId><ArticleId IdType="pubmed">11526389</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourneau J.M., Bach J.M., van Endert P.M., Bach J.F. The elusive case for a role of mimicry in autoimmune diseases. Mol. Immunol. 2004;40:1095–1102. doi: 10.1016/j.molimm.2003.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2003.11.011</ArticleId><ArticleId IdType="pubmed">15036914</ArticleId></ArticleIdList></Reference><Reference><Citation>Damian R.T. Molecular Mimicry in Biological Adaptation. Science. 1965;147:824. doi: 10.1126/science.147.3660.824.c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.147.3660.824.c</ArticleId><ArticleId IdType="pubmed">17793550</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy L., Tsunoda I., Fujinami R.S. Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity. 2006;39:9–19. doi: 10.1080/08916930500484799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500484799</ArticleId><ArticleId IdType="pubmed">16455578</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami R.S., von Herrath M.G., Christen U., Whitton J.L. Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease. Clin. Microbiol. Rev. 2006;19:80–94. doi: 10.1128/CMR.19.1.80-94.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.19.1.80-94.2006</ArticleId><ArticleId IdType="pmc">PMC1360274</ArticleId><ArticleId IdType="pubmed">16418524</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco Y., Acosta-Ampudia Y., Monsalve D.M., Chang C., Gershwin M.E., Anaya J.M. Bystander activation and autoimmunity. J. Autoimmun. 2019;103:102301. doi: 10.1016/j.jaut.2019.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.06.012</ArticleId><ArticleId IdType="pubmed">31326230</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose N.R. Negative selection, epitope mimicry and autoimmunity. Curr. Opin. Immunol. 2017;49:51–55. doi: 10.1016/j.coi.2017.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2017.08.014</ArticleId><ArticleId IdType="pubmed">29102863</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions. Int. J. Mol. Sci. 2020;21:4645. doi: 10.3390/ijms21134645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21134645</ArticleId><ArticleId IdType="pmc">PMC7369971</ArticleId><ArticleId IdType="pubmed">32629865</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Int. J. Mol. Sci. 2021;22:2108. doi: 10.3390/ijms22042108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22042108</ArticleId><ArticleId IdType="pmc">PMC7924650</ArticleId><ArticleId IdType="pubmed">33672738</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children. Int. J. Mol. Sci. 2023;24:3001. doi: 10.3390/ijms24033001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24033001</ArticleId><ArticleId IdType="pmc">PMC9917907</ArticleId><ArticleId IdType="pubmed">36769320</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotz P.H. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet. 1983;2:824–826. doi: 10.1016/S0140-6736(83)90740-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(83)90740-7</ArticleId><ArticleId IdType="pubmed">6137652</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzioufas A.G., Routsias J.G. Idiotype, anti-idiotype network of autoantibodies: Pathogenetic considerations and clinical application. Autoimmun. Rev. 2010;9:631–633. doi: 10.1016/j.autrev.2010.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2010.05.013</ArticleId><ArticleId IdType="pubmed">20478412</ArticleId></ArticleIdList></Reference><Reference><Citation>Westall F.C., Root-Bernstein R.S. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol. Immunol. 1983;20:169–177. doi: 10.1016/0161-5890(83)90128-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0161-5890(83)90128-1</ArticleId><ArticleId IdType="pubmed">6188949</ArticleId></ArticleIdList></Reference><Reference><Citation>Westall F.C., Root-Bernstein R. Cause and prevention of postinfectious and postvaccinal neuropathies in light of a new theory of autoimmunity. Lancet. 1986;2:251–252. doi: 10.1016/S0140-6736(86)92073-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(86)92073-8</ArticleId><ArticleId IdType="pubmed">2426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R.S. Multiple-antigen-mediated autoimmunity (MAMA) in AIDS: A possible model for postinfectious autoimmune complications. Res. Immunol. 1990;141:321–339. doi: 10.1016/0923-2494(90)90024-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0923-2494(90)90024-S</ArticleId><ArticleId IdType="pubmed">2267409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann G.W., Kion T.A., Grant M.D. An idiotypic network model of AIDS immunopathogenesis. Proc. Natl. Acad. Sci. USA. 1991;88:3060–3064. doi: 10.1073/pnas.88.8.3060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.8.3060</ArticleId><ArticleId IdType="pmc">PMC51384</ArticleId><ArticleId IdType="pubmed">1901653</ArticleId></ArticleIdList></Reference><Reference><Citation>Süsal C., Hoffman G.W., Daniel V., Grant M., Opelz G. Complementarities and network interactions in AIDS. J. Autoimmun. 1993;6:601–610. doi: 10.1006/jaut.1993.1049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.1993.1049</ArticleId><ArticleId IdType="pubmed">8240663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergraft W.F., 3rd, Preston G.A., Shah R.R., Tropsha A., Carter C.W., Jr., Jennette J.C., Falk R.J. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004;10:72–79. doi: 10.1038/nm968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm968</ArticleId><ArticleId IdType="pubmed">14661018</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergraft W.F., 3rd, Pressler B.M., Jennette J.C., Falk R.J., Preston G.A. Autoantigen complementarity: A new theory implicating complementary proteins as initiators of autoimmune disease. J. Mol. Med. 2005;83:12–25. doi: 10.1007/s00109-004-0615-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-004-0615-3</ArticleId><ArticleId IdType="pubmed">15592920</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Bautz D.J., Lionaki S., Hogan S.L., Chin H., Tisch R.M., Schmitz J.L., Pressler B.M., Jennette J.C., Falk R.J., et al. ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int. 2008;74:1159–1169. doi: 10.1038/ki.2008.309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2008.309</ArticleId><ArticleId IdType="pmc">PMC2754720</ArticleId><ArticleId IdType="pubmed">18596726</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds J., Preston G.A., Pressler B.M., Hewins P., Brown M., Roth A., Alderman E., Bunch D., Jennette J.C., Cook H.T., et al. Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by ‘autoantigen complementarity’. J. Autoimmun. 2015;59:8–18. doi: 10.1016/j.jaut.2015.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.01.003</ArticleId><ArticleId IdType="pmc">PMC4459745</ArticleId><ArticleId IdType="pubmed">25841937</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy. Anticancer Agents Med. Chem. 2015;15:1242–1259. doi: 10.2174/1871520615666150716105057.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871520615666150716105057</ArticleId><ArticleId IdType="pubmed">26179268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishino Y., Krupovic M., Forterre P. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology. J. Bacteriol. 2018;200:e00580-17. doi: 10.1128/JB.00580-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00580-17</ArticleId><ArticleId IdType="pmc">PMC5847661</ArticleId><ArticleId IdType="pubmed">29358495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein R.M., Schluter S.F., Bernstein H., Marchalonis J.J. Primordial emergence of the recombination activating gene 1 (RAG1): Sequence of the complete shark gene indicates homology to microbial integrases. Proc. Natl. Acad. Sci. USA. 1996;93:9454–9459. doi: 10.1073/pnas.93.18.9454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.18.9454</ArticleId><ArticleId IdType="pmc">PMC38449</ArticleId><ArticleId IdType="pubmed">8790351</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A., Eastman Q.M., Schatz D.G. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature. 1998;394:744–751. doi: 10.1038/29457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/29457</ArticleId><ArticleId IdType="pubmed">9723614</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux C.A., Pontarotti P., Nehari S., Raoult D. ‘Cannibalism’ of exogenous DNA sequences: The ancestral form of adaptive immunity which entails recognition of danger. Front. Immunol. 2022;13:989707. doi: 10.3389/fimmu.2022.989707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.989707</ArticleId><ArticleId IdType="pmc">PMC9816338</ArticleId><ArticleId IdType="pubmed">36618387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell C., Dray S. Conversion of non-immune rabbit spleen cells by ribonucleic acid of lymphoid cells from an immunized rabbit to produce IgM and IgG antibody of foreign heavy-chain allotype. J. Immunol. 1971;107:83–95. doi: 10.4049/jimmunol.107.1.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.107.1.83</ArticleId><ArticleId IdType="pubmed">4997118</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler F.L., Fishman M., Dray S. Antibody formation initiated in vitro. 3. Antibody formation and allotypic specificity directed by ribonucleic acid from peritoneal exudate cells. J. Immunol. 1966;97:554–558. doi: 10.4049/jimmunol.97.4.554.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.97.4.554</ArticleId><ArticleId IdType="pubmed">5957259</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainboim L., Sztein M.B., Serrate S., Satz L. In vitro transfer of cellular immunity in experimental allergic orchitis by means of immune RNA. Immunology. 1979;38:311–316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1457946</ArticleId><ArticleId IdType="pubmed">511220</ArticleId></ArticleIdList></Reference><Reference><Citation>Satz M.L., Sztein M.B., Serrate S., Braun M. Mechanism of immune transfer by RNA ex-tracts. Immune RNA induces the synthesis of idiotype-bearing antigen receptors in non-committed cells. Mol. Cell Biochem. 1980;33:105–113. doi: 10.1007/BF00225282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00225282</ArticleId><ArticleId IdType="pubmed">6162092</ArticleId></ArticleIdList></Reference><Reference><Citation>Theurer K. Eine neue Instruktionstheorie. Möglichkeiten einer rückläufigen infor-mationsübertragung von Polypeptidsequenzen auf RNA, insbesondere bei der Anti-körpersynthese, sowie Mechanismen der Toleranzerzeugung und Immunsuppression [A new instruction theory: Possibility of a reverse flow of information from polypeptide se-quences to RNA particularly in antibody synthesis, and the mechanisms of tolerance in-duction and immunosuppression (author’s transl)] Infection. 1975;3:178–182. doi: 10.1007/BF01641347. (In German)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01641347</ArticleId><ArticleId IdType="pubmed">57102</ArticleId></ArticleIdList></Reference><Reference><Citation>Root Bernstein R.S. Self, Nonself, and the Paradoxes of Autoimmunity. In: Tauber A.I., editor. Organism and the Development of Self. Kluwer; Boston, MA, USA: 1991. pp. 159–209.</Citation></Reference><Reference><Citation>Viza D., Fudenberg H.H., Palareti A., Ablashi D., De Vinci C., Pizza G. Transfer factor: An overlooked potential for the prevention and treatment of infectious diseases. Folia Biol. 2013;59:53–67.</Citation><ArticleIdList><ArticleId IdType="pubmed">23746171</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. The Mysterious, and Potentially Revolutionary, Immunological Properties of Transfer Factor: A Review. Preprints. 2019.  [(accessed on 24 January 2024)]. p. 2019050386. Available online:  https://www.preprints.org/manuscript/201905.0386/v1.</Citation></Reference><Reference><Citation>Hara N., Alkanani A.K., Ir D., Robertson C.E., Wagner B.D., Frank D.N., Zipris D. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J. Immunol. 2012;189:3805–3814. doi: 10.4049/jimmunol.1201257.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201257</ArticleId><ArticleId IdType="pubmed">22988033</ArticleId></ArticleIdList></Reference><Reference><Citation>Viza D., Boucheix C., Kern D.H., Pilch Y.H. Human lymphoblastoid cells in culture replicate immune information carried by xenogeneic RNA. Differentiation. 1978;11:181–184. doi: 10.1111/j.1432-0436.1978.tb00982.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-0436.1978.tb00982.x</ArticleId><ArticleId IdType="pubmed">720786</ArticleId></ArticleIdList></Reference><Reference><Citation>Passos Júnior G.A., de Lucca F.L. RNA-mediated transfer of cellular immunity to a synthetic env antigen of the human immunodeficiency virus (HIV-1) Mol. Cell Biochem. 1991;108:1–8. doi: 10.1007/BF00239536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00239536</ArticleId><ArticleId IdType="pubmed">1722867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanca A., Palomba A., Fraumene C., Manghina V., Silverman M., Uzzau S. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice. mSphere. 2018;3:e00492-18. doi: 10.1128/mSphere.00492-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00492-18</ArticleId><ArticleId IdType="pmc">PMC6200989</ArticleId><ArticleId IdType="pubmed">30355671</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Shan K., Pan L.L., Feng N., Lv Z., Sun Y., Li J., Wu C., Zhang H., Chen W., et al. Clostridium butyricum CGMCC0313.1 Protects against Autoimmune Diabetes by Modu-lating Intestinal Immune Homeostasis and Inducing Pan-creatic Regulatory T Cells. Front. Immunol. 2017;8:1345. doi: 10.3389/fimmu.2017.01345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01345</ArticleId><ArticleId IdType="pmc">PMC5654235</ArticleId><ArticleId IdType="pubmed">29097999</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Li D., Feng N., Shamoon M., Sun Z., Ding L., Zhang H., Chen W., Sun J., Chen Y.Q. Anti-diabetic Effects of Clos-tridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice. Sci. Rep. 2017;7:7046. doi: 10.1038/s41598-017-07335-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07335-0</ArticleId><ArticleId IdType="pmc">PMC5539151</ArticleId><ArticleId IdType="pubmed">28765642</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Li Y.Y., Liu Y. Effect of fecal microbiota transplantation on type 1 diabetes mellitus in non-obese diabetic mice and its underlying mechanism. Zhonghua Yi Xue Za Zhi. 2022;102:1224–1231. doi: 10.3760/cma.j.cn112137-20210907-02043. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112137-20210907-02043</ArticleId><ArticleId IdType="pubmed">35462505</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafeek R.A.M., Sikder S., Hamlin A.S., Andronicos N.M., McMillan D.J., Sriprakash K.S., Ketheesan N. Requirements for a Robust Animal Model to Investigate the Disease Mechanism of Autoimmune Complications Associated With ARF/RHD. Front. Cardiovasc. Med. 2021;8:675339. doi: 10.3389/fcvm.2021.675339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.675339</ArticleId><ArticleId IdType="pmc">PMC8131511</ArticleId><ArticleId IdType="pubmed">34026876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Frisancho-Kiss S., Rose N.R. Viruses as adjuvants for autoimmunity: Evidence from Coxsackievirus-induced myocarditis. Rev. Med. Virol. 2005;15:17–27. doi: 10.1002/rmv.445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.445</ArticleId><ArticleId IdType="pubmed">15386590</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M.W. Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae. Microbiol. Spectr. 2019;7 doi: 10.1128/microbiolspec.GPP3-0045-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.GPP3-0045-2018</ArticleId><ArticleId IdType="pmc">PMC6684244</ArticleId><ArticleId IdType="pubmed">31373269</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R., Huber J., Ziehl A., Pietrowicz M. SARS-CoV-2 and Its Bacterial Co- or Super-Infections Synergize to Trigger COVID-19 Autoimmune Cardiopathies. Int. J. Mol. Sci. 2023;24:12177. doi: 10.3390/ijms241512177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241512177</ArticleId><ArticleId IdType="pmc">PMC10418384</ArticleId><ArticleId IdType="pubmed">37569555</ArticleId></ArticleIdList></Reference><Reference><Citation>Allakany A.I., Elbanna A.A., Rohoma K.H., Ahmed S.M., Ibrahim A.E., Fawzy M.A., Header D.A. Study of the gut microbiome in Egyptian patients with type 1 diabetes mellitus. Prz. Gastroenterol. 2023;18:190–197. doi: 10.5114/pg.2023.126055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pg.2023.126055</ArticleId><ArticleId IdType="pmc">PMC10395059</ArticleId><ArticleId IdType="pubmed">37538290</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamahane V., Bhanushali S., Shah N., Gupta A., Khadilkar V., Gondhalekar K., Khadil-kar A., Shouche Y. A comparative study of the gut microbiome in Indian children with type 1 diabetes and healthy controls. J. Diabetes. 2023 doi: 10.1111/1753-0407.13438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13438</ArticleId><ArticleId IdType="pmc">PMC11070843</ArticleId><ArticleId IdType="pubmed">37381634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Cruz C., Perez-Shibayama C., De Martin A., Ronchi F., van der Borght K., Niederer R., Onder L., Lütge M., Novkovic M., Nindl V., et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science. 2019;366:881–886. doi: 10.1126/science.aav3487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav3487</ArticleId><ArticleId IdType="pubmed">31727837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X.F., Zhang W.Y., Wen Q., Chen W.J., Wang Z.M., Chen J., Zhu F., Liu K., Cheng L.X., Yang J., et al. Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition. Pharmacol. Res. 2019;139:412–421. doi: 10.1016/j.phrs.2018.11.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.11.042</ArticleId><ArticleId IdType="pubmed">30508676</ArticleId></ArticleIdList></Reference><Reference><Citation>Neu U., Mainou B.A. Virus interactions with bacteria: Partners in the infectious dance. PLoS Pathog. 2020;16:e1008234. doi: 10.1371/journal.ppat.1008234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008234</ArticleId><ArticleId IdType="pmc">PMC7012391</ArticleId><ArticleId IdType="pubmed">32045465</ArticleId></ArticleIdList></Reference><Reference><Citation>Usviatsov B., Pan’kov A.S., Bukharin O.V. Mechanisms of interaction of associative symbionts during viral-bacterial infections. Zh Mikrobiol Epidemiol Immunobiol. 2009;2:117–121.</Citation><ArticleIdList><ArticleId IdType="pubmed">19462521</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera E.R., Nguyen Y., Sasaki J., Pfeiffer J.K. Bacterial Stabilization of a Panel of Picornaviruses. mSphere. 2019;4:e00183-19. doi: 10.1128/mSphere.00183-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00183-19</ArticleId><ArticleId IdType="pmc">PMC6449606</ArticleId><ArticleId IdType="pubmed">30944213</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman P., Meseguer A., Lucas F., Moulin L., Wurtzer S. Interaction of Human Enteric Viruses with Microbial Compounds: Implication for Virus Persistence and Disinfection Treatments. Environ. Sci. Technol. 2017;51:13633–13640. doi: 10.1021/acs.est.7b03875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.est.7b03875</ArticleId><ArticleId IdType="pubmed">29116763</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Ma W.-T., Pang M., Fan Q.-L., Hua J.-L. The Commensal Microbiota and Viral Infection: A Comprehensive Review. Front. Immunol. 2019;10:1551. doi: 10.3389/fimmu.2019.01551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01551</ArticleId><ArticleId IdType="pmc">PMC6620863</ArticleId><ArticleId IdType="pubmed">31333675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Z., Xiong D., Shi J., Long M., Chen Z. The Interaction Between Viruses and Intestinal Microbiota: A Review. Curr. Microbiol. 2021;78:3597–3608. doi: 10.1007/s00284-021-02623-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-021-02623-5</ArticleId><ArticleId IdType="pmc">PMC8336530</ArticleId><ArticleId IdType="pubmed">34350485</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson C.M. Enteric viruses exploit the microbiota to promote infection. Curr. Opin. Virol. 2019;37:58–62. doi: 10.1016/j.coviro.2019.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2019.06.002</ArticleId><ArticleId IdType="pmc">PMC6768720</ArticleId><ArticleId IdType="pubmed">31284078</ArticleId></ArticleIdList></Reference><Reference><Citation>Barin J.G., Talor M.V., Diny N.L., Ong S., Schaub J.A., Gebremariam E., Bedja D., Chen G., Choi H.S., Hou X., et al. Regulation of autoimmune myocarditis by host responses to the microbiome. Exp. Mol. Pathol. 2017;103:141–152. doi: 10.1016/j.yexmp.2017.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC5721523</ArticleId><ArticleId IdType="pubmed">28822770</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., Chen R., Zhang B., Zhang S., Khan B.A., Zhu D., Wu Z., Xiao C., Chen B., Chen F., et al. Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus. Front. Immunol. 2022;13:930872. doi: 10.3389/fimmu.2022.930872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.930872</ArticleId><ArticleId IdType="pmc">PMC9414079</ArticleId><ArticleId IdType="pubmed">36032108</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Deng F., Chen J., Chen F., Wu Z., Li L., Hou K. Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review. Front. Cell Infect. Microbiol. 2022;12:1075201. doi: 10.3389/fcimb.2022.1075201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1075201</ArticleId><ArticleId IdType="pmc">PMC9751335</ArticleId><ArticleId IdType="pubmed">36530444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadj Hassine I., Gharbi J., Amara I., Alyami A., Subei R., Almalki M., Hober D., M’hadheb M.B. Cloning and Molecular Characterization of the Recombinant CVB4E2 Immunogenic Viral Protein (rVP1), as a Potential Subunit Protein for Vaccine and Immunodiagnostic Reagent Candidate. Microorganisms. 2023;11:1192. doi: 10.3390/microorganisms11051192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11051192</ArticleId><ArticleId IdType="pmc">PMC10222663</ArticleId><ArticleId IdType="pubmed">37317166</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharbi J., Almalki M.A., Ben M’hadheb M. The introduction of mutations in the wild type coxsackievirus B3 (CVB3) IRES RNA leads to different levels of in vitro reduced replicative and translation efficiencies. PLoS ONE. 2022;17:e0274162. doi: 10.1371/journal.pone.0274162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274162</ArticleId><ArticleId IdType="pmc">PMC9529112</ArticleId><ArticleId IdType="pubmed">36190999</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankaniemi M.M., Stone V.M., Andrejeff T., Heinimäki S., Sioofy-Khojine A.B., Marjomäki V., Hyöty H., Blazevic V., Flodström-Tullberg M., Hytönen V.P., et al. Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine. Antivir. Res. 2019;171:104595. doi: 10.1016/j.antiviral.2019.104595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.104595</ArticleId><ArticleId IdType="pubmed">31491431</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhang C., Li J., Dai Z., Huang J., Deng F., Wang X., Yue X., Hu X., Li Y., et al. Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches. Front. Immunol. 2022;13:933594. doi: 10.3389/fimmu.2022.933594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.933594</ArticleId><ArticleId IdType="pmc">PMC9682020</ArticleId><ArticleId IdType="pubmed">36439191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharbi J., Hadj Hassine I., Hassine M., Al-Malki M., Al-Yami A., Al-Bachir A., Ben M’hadheb M. Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model. Viruses. 2023;15:878. doi: 10.3390/v15040878.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040878</ArticleId><ArticleId IdType="pmc">PMC10145976</ArticleId><ArticleId IdType="pubmed">37112858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyöty H., Leon F., Knip M. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert. Rev. Vaccines. 2018;17:1071–1083. doi: 10.1080/14760584.2018.1548281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1548281</ArticleId><ArticleId IdType="pubmed">30449209</ArticleId></ArticleIdList></Reference><Reference><Citation>Drescher K.M., von Herrath M., Tracy S. Enteroviruses, hygiene and type 1 diabetes: Toward a preventive vaccine. Rev. Med. Virol. 2015;25:19–32. doi: 10.1002/rmv.1815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1815</ArticleId><ArticleId IdType="pubmed">25430610</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson P.G., Lakshmikanth T., Laitinen O.H., Utorova R., Jacobson S., Oikarinen M., Domsgen E., Koivunen M.R., Chaux P., Devard N., et al. A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia. 2015;58:346–354. doi: 10.1007/s00125-014-3436-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-014-3436-0</ArticleId><ArticleId IdType="pubmed">25370797</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone V.M., Butrym M., Hankaniemi M.M., Sioofy-Khojine A.B., Hytönen V.P., Hyöty H., Flodström-Tullberg M. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect. Diabetes. 2021;70:2871–2878. doi: 10.2337/db21-0193.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0193</ArticleId><ArticleId IdType="pmc">PMC8660981</ArticleId><ArticleId IdType="pubmed">34497136</ArticleId></ArticleIdList></Reference><Reference><Citation>Höfling K., Kim K.S., Leser J.S., Chapman N.M., Willian S., Gauntt C.J., Tracy S. Progress toward vaccines against viruses that cause heart disease. Herz. 2000;25:286–290. doi: 10.1007/s000590050022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000590050022</ArticleId><ArticleId IdType="pubmed">10904854</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N.M., Tracy S. Can recombinant DNA technology provide useful vaccines against viruses which induce heart disease? Eur. Heart J. 1995;16:144–146. doi: 10.1093/eurheartj/16.suppl_O.144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/16.suppl_O.144</ArticleId><ArticleId IdType="pubmed">8682083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Parham N.J., Zhang F., Aasa-Chapman M., Gould E.A., Zhang H. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Vaccine. 2012;30:2301–2308. doi: 10.1016/j.vaccine.2012.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.01.061</ArticleId><ArticleId IdType="pubmed">22306858</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zhang Y., Li H., Liu L. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines. Int. J. Mol. Sci. 2022;24:169. doi: 10.3390/ijms24010169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010169</ArticleId><ArticleId IdType="pmc">PMC9820767</ArticleId><ArticleId IdType="pubmed">36613612</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke A., Jarasch N., Martin U., Wegert J., Wildner A., Zell R., Wutzler P. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease. Int. J. Med. Microbiol. 2008;298:127–134. doi: 10.1016/j.ijmm.2007.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmm.2007.08.010</ArticleId><ArticleId IdType="pubmed">17897883</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley T.V., Lyras D., Douce G.R. Status of vaccine research and development for Clostridium difficile. Vaccine. 2019;37:7300–7306. doi: 10.1016/j.vaccine.2019.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.02.052</ArticleId><ArticleId IdType="pubmed">30902484</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski J., Zorman J., Wang S., Miezeiewski M., Xie J., Soring K., Petrescu I., Rogers I., Thiriot D.S., Cook J.C., et al. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Vaccine. 2014;32:2812–2818. doi: 10.1016/j.vaccine.2014.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.02.026</ArticleId><ArticleId IdType="pubmed">24662701</ArticleId></ArticleIdList></Reference><Reference><Citation>Foglia G., Shah S., Luxemburger C., Pietrobon P.J. Clostridium difficile: Development of a novel candidate vaccine. Vaccine. 2012;30:4307–4309. doi: 10.1016/j.vaccine.2012.01.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.01.056</ArticleId><ArticleId IdType="pubmed">22682287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J.H., Glenn G., Flyer D., Zhou B., Liu Y., Sullivan E., Wu H., Cummings J.F., Elllingsworth L., Smith G. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models. Vaccine. 2017;35:4079–4087. doi: 10.1016/j.vaccine.2017.06.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.06.062</ArticleId><ArticleId IdType="pubmed">28669616</ArticleId></ArticleIdList></Reference><Reference><Citation>Anosova N.G., Brown A.M., Li L., Liu N., Cole L.E., Zhang J., Mehta H., Kleanthous H. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters. J. Med. Microbiol. 2013;62:1394–1404. doi: 10.1099/jmm.0.056796-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.056796-0</ArticleId><ArticleId IdType="pubmed">23518659</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuler J., Chandra H., Sun X. Mucosal Vaccination Strategies against Clostridioides difficile Infection. Vaccines. 2023;11:887. doi: 10.3390/vaccines11050887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11050887</ArticleId><ArticleId IdType="pmc">PMC10223210</ArticleId><ArticleId IdType="pubmed">37242991</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer A.C., Carapetis J.R., Dale J.B., Fraser J.D., Good M.F., Guilherme L., Moreland N.J., Mulholland E.K., Schodel F., Smeesters P.R. Status of research and development of vaccines for Streptococcus pyogenes. Vaccine. 2016;34:2953–2958. doi: 10.1016/j.vaccine.2016.03.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.03.073</ArticleId><ArticleId IdType="pubmed">27032515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M., Good M.F. The quest for GAS vaccine. Oncotarget. 2015;6:34063–34064. doi: 10.18632/oncotarget.6140.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6140</ArticleId><ArticleId IdType="pmc">PMC4741433</ArticleId><ArticleId IdType="pubmed">26485764</ArticleId></ArticleIdList></Reference><Reference><Citation>Giffard P.M., Tong S.Y.C., Holt D.C., Ralph A.P., Currie B.J. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease. PLoS Negl. Trop. Dis. 2019;13:e0007511. doi: 10.1371/journal.pntd.0007511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007511</ArticleId><ArticleId IdType="pmc">PMC6634427</ArticleId><ArticleId IdType="pubmed">31269021</ArticleId></ArticleIdList></Reference><Reference><Citation>Britanova O.V., Putintseva E.V., Shugay M., Merzlyak E.M., Turchaninova M.A., Staroverov D.B., Bolotin D.A., Lukyanov S., Bogdanova E.A., Mamedov I.Z., et al. Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J. Immunol. 2014;192:2689–2698. doi: 10.4049/jimmunol.1302064.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302064</ArticleId><ArticleId IdType="pubmed">24510963</ArticleId></ArticleIdList></Reference><Reference><Citation>Probert C.S., Chott A., Turner J.R., Saubermann L.J., Stevens A.C., Bodinaku K., Elson C.O., Balk S.P., Blumberg R.S. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. J. Immunol. 1996;157:3183–3191. doi: 10.4049/jimmunol.157.7.3183.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.157.7.3183</ArticleId><ArticleId IdType="pubmed">8816432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng W., Maciejewski J.P., Chen G., Young N.S. Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J. Clin. Investig. 2001;108:765–773. doi: 10.1172/JCI200112687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200112687</ArticleId><ArticleId IdType="pmc">PMC209382</ArticleId><ArticleId IdType="pubmed">11544283</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamedov I.Z., Britanova O.V., Bolotin D.A., Chkalina A.V., Staroverov D.B., Zvyagin I.V., Kotlobay A.A., Turchaninova M.A., Fedorenko D.A., Novik A.A., et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol. Med. 2011;3:201–207. doi: 10.1002/emmm.201100129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201100129</ArticleId><ArticleId IdType="pmc">PMC3377069</ArticleId><ArticleId IdType="pubmed">21374820</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman J.D., Klein J.T., Silver R.F., Liu M.C., Greenlee B.M., Moller D.R. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J. Clin. Investig. 1994;94:1533–1542. doi: 10.1172/JCI117494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI117494</ArticleId><ArticleId IdType="pmc">PMC295302</ArticleId><ArticleId IdType="pubmed">7929830</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan S., Vignali M., Klinger M., Dines J., Kaplan I., Svejnoha E., Craft T., Boland K., Pesesky M., Gittelman R.M., et al.  A Large-Scale Database of T-Cell Receptor Beta (TCRb) Sequences and Binding Associations from Natural and Synthetic Exposure to SARS-CoV-2. 2020.  [(accessed on 20 November 2022)].  Available online:  https://clients.adaptivebiotech.com/pub/covid-2020.</Citation></Reference><Reference><Citation>Durinovic-Bello I., Steinle A., Ziegler A.G., Schendel D.J. 1994. HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient. T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes. 1994;43:1318–1325. doi: 10.2337/diab.43.11.1318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.43.11.1318</ArticleId><ArticleId IdType="pubmed">7926306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., Hering B.J., Hafler D.A. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature. 2005;435:224–228. doi: 10.1038/nature03625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03625</ArticleId><ArticleId IdType="pubmed">15889096</ArticleId></ArticleIdList></Reference><Reference><Citation>Seay H.R., Yusko E., Rothweiler S.J., Zhang L., Posgai A.L., Campbell-Thompson M., Vignali M., Emerson R.O., Kaddis J.S., Ko D., et al. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes. JCI Insight. 2016;1:e88242. doi: 10.1172/jci.insight.88242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.88242</ArticleId><ArticleId IdType="pmc">PMC5135280</ArticleId><ArticleId IdType="pubmed">27942583</ArticleId></ArticleIdList></Reference><Reference><Citation>Luppi P., Rudert W., Licata A., Riboni S., Betters D., Cotrufo M., Frati G., Condorelli G., Trucco M. Expansion of specific alphabeta+ T-cell subsets in the myocardium of patients with myocarditis and idiopathic dilated cardiomyopathy associated with Coxsackievirus B infection. Hum. Immunol. 2003;64:194–210. doi: 10.1016/S0198-8859(02)00798-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0198-8859(02)00798-X</ArticleId><ArticleId IdType="pubmed">12559622</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>